NYSEARCA:CNCR Loncar Cancer Immunotherapy ETF - CNCR Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Loncar Cancer Immunotherapy ETF Please log in to your account or sign up in order to add this asset to your watchlist. $15.16 +0.20 (+1.34%) (As of 02/2/2023 12:00 AM ET) Add Share Share Today's Range$14.96▼$15.1850-Day Range$13.14▼$15.1852-Week Range$12.76▼$19.67Volume2,652 shsAverage Volume2,725 shsMarket Capitalization$22.74 millionP/E RatioN/ADividend Yield0.00%Price TargetN/A ProfileChart Receive CNCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Loncar Cancer Immunotherapy ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CNCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Loncar Cancer Immunotherapy ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Basic Details Issuer Exchange Traded Concepts Fund NameLoncar Cancer Immunotherapy ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:CNCR Inception Date10/13/2015 Fund ManagerDenise M. Krisko WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLoncar Cancer Immunotherapy Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$22.79 million Average Daily Volume$2,768.90 Discount/Premium-0.03% ETF Expenses Management Fee0.79% Other Expenses0.00% Total Expenses0.79% Fee Waiver0.00% Net Expenses0.79%Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorExchange Traded Concepts, LLC CustodianU.S. Bank, N.A. DistributorQuasar Distributors, LLC Transfer AgentU.S. Bank, N.A. Trustee Lead Market MakerJane Street Geographic Exposure of CNCRCurrency Exposure of CNCRSector Exposure of CNCRIndustry Exposure of CNCR CNCR Stock - Frequently Asked Questions How have CNCR shares performed in 2023? Loncar Cancer Immunotherapy ETF's stock was trading at $13.73 at the beginning of 2023. Since then, CNCR shares have increased by 10.4% and is now trading at $15.16. View the best growth stocks for 2023 here. What other stocks do shareholders of Loncar Cancer Immunotherapy ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar Cancer Immunotherapy ETF investors own include Inovio Pharmaceuticals (INO), ARK Genomic Revolution Multi-Sector ETF (ARKG), VanEck Biotech ETF (BBH), Co-Diagnostics (CODX), Danaher (DHR), Fate Therapeutics (FATE), Gilead Sciences (GILD), GenMark Diagnostics (GNMK), iShares Genomics Immunology and Healthcare ETF (IDNA) and Novavax (NVAX). What is Loncar Cancer Immunotherapy ETF's stock symbol? Loncar Cancer Immunotherapy ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CNCR." How do I buy shares of Loncar Cancer Immunotherapy ETF? Shares of CNCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Loncar Cancer Immunotherapy ETF's stock price today? One share of CNCR stock can currently be purchased for approximately $15.16. How much money does Loncar Cancer Immunotherapy ETF make? Loncar Cancer Immunotherapy ETF (NYSEARCA:CNCR) has a market capitalization of $22.74 million. This page (NYSEARCA:CNCR) was last updated on 2/3/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.